Mineral composition of UFC, B, and SF. by Junxia Zhou (14381598)

Subjects:

Fig 8 - by Junxia Zhou (14381598)

Subjects:

Adult <i>Shroom3</i>^<i>+</i>^<i>/Gt</i> hearts show decreased cardiomyocyte cross-sectional area. by Jennifer L. Carleton (22208916)

Subjects:

Forest plot between UCAR and cognitive impairment. by Yubo Teng (21246745)

Subjects:

Between the PCSO-524 group and the placebo group unpaired comparisons of the change between visits of quality of life and respiratory variables scores. by Nattapon Riengvirodkij (11268720)

Subjects:

Flowchart of participants in this study. by Yubo Teng (21246745)

Subjects:

A flow diagram outlining the number of dogs in each group during the study (visit 1 = day 0, visit 2 = day 35, and visit 3 = day 70). by Nattapon Riengvirodkij (11268720)

Subjects:

Nonlinear relationship between UACR and cognitive impairment. by Yubo Teng (21246745)

Subjects:

Distribution of quality of life and respiratory variables scores of all 3 visits (visit = day 0, visit 2 = day 35, and visit 3 = day 70) of the PCSO-524 group and the placebo group... by Nattapon Riengvirodkij (11268720)

Subjects:

The baseline characteristics of classifications and body condition score of the 2 groups (frequencies) at entry (visit 1, day 0). by Nattapon Riengvirodkij (11268720)

Subjects:

Threshold effect analysis of UACR and cognitive impairment. by Yubo Teng (21246745)

Subjects:

Analyzing the relationship between UACR (<30) and cognitive scores and impairment. by Yubo Teng (21246745)

Subjects:

Analyzing the relationship between UACR and cognitive scores and impairment. by Yubo Teng (21246745)

Subjects:

Distribution of continuous variables of all 3 visits (visit 1 = day 0, visit 2 = day 35, and visit 3 = day 70) of the PCSO-524 group and the placebo group. Results are shown as mea... by Nattapon Riengvirodkij (11268720)

Subjects:

Tricuspid regurgitation pressure gradient of all 17 dogs. by Nattapon Riengvirodkij (11268720)

Subjects:

Tricuspid regurgitation pressure gradient in the PCSO-524 and placebo groups. by Nattapon Riengvirodkij (11268720)

Subjects:

Baseline characteristics of participants (N = 2385) by UACR. by Yubo Teng (21246745)

Subjects:

S2 File - Factors influencing effective decrease of controlled attenuation parameters in metabolic-associated steatotic liver disease: A multilevel linear regression analysis at Va... by Sonsawan Sangprasert (22772538)

Charts revealing A) the significant decrease (<i>p</i> < 0.05) in the membrane integrity and B) the significant increase (<i>p</i> < 0.05) in the membrane permeability after treatment with harmalacidine hydrochloride in a representative <i>S. aureus</i> isolate (n = 3 as technical repeats of the same isolate). by Manal A. Alossaimi (10269852)

“…<p>Charts revealing A) the significant decrease (<i>p</i> < 0.05) in the membrane integrity and B) the significant increase (<i>p</i> < 0.05) in the membrane permeability after treatment with harmalacidine hydrochloride in a representative <i>S. aureus</i> isolate (n = 3 as technical repeats of the same isolate).…”

Box plots showing baseline prevalence and mean egg count at pre-MDA1 in districts that were responders compared to those that were persistent hotspots of decreasing praziquantel ef... by Takafira Mduluza (39754)